ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
Alzamend Neuro, Inc.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 10, 2026
$1.33+0.03 (+2.31%)
Close on Oct 19, 2026
- Market cap
- $5.96M
- P/E (TTM)
- –
- Dividend yield
- –
Charting library not installed
Copy the licensed TradingView charting_library folder to apps/web/public/charting_library/, or set TV_LIBRARY_PATH, then reload. Setup steps are in docs/ADVANCED-CHARTS.md.